دورية أكاديمية

Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study

التفاصيل البيبلوغرافية
العنوان: Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study
المؤلفون: Scheltens, PhilipAff1, Hallikainen, MerjaAff2, Grimmer, TimoAff3, Duning, ThomasAff4, Gouw, Alida AAff1, Aff5, Teunissen, Charlotte EAff6, Wink, Alle MeijeAff7, Maruff, PaulAff8, Harrison, JohnAff1, Aff9, van Baal, Caroline MAff10, Bruins, SuzanneAff11, Lues, IngeAff11, Prins, Niels DAff1, Aff12
المصدر: Alzheimer's Research & Therapy. 10(1)
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:17589193
DOI:10.1186/s13195-018-0431-6